6.36
-0.10 (-1.55%)
| Penutupan Terdahulu | 6.46 |
| Buka | 6.34 |
| Jumlah Dagangan | 104,690 |
| Purata Dagangan (3B) | 1,345,090 |
| Modal Pasaran | 345,206,816 |
| Harga / Pendapatan (P/E Ke hadapan) | 14.81 |
| Harga / Jualan (P/S) | 0.250 |
| Harga / Buku (P/B) | 0.530 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 4 Aug 2025 - 8 Aug 2025 |
| Margin Keuntungan | -18.26% |
| Margin Operasi (TTM) | -2.21% |
| EPS Cair (TTM) | -3.60 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | -29.60% |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 140.04% |
| Nisbah Semasa (MRQ) | 3.69 |
| Aliran Tunai Operasi (OCF TTM) | 58.70 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | 58.50 M |
| Pulangan Atas Aset (ROA TTM) | -2.03% |
| Pulangan Atas Ekuiti (ROE TTM) | -33.67% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Drug Manufacturers - Specialty & Generic (US) | Menurun | Bercampur |
| Drug Manufacturers - Specialty & Generic (Global) | Menurun | Bercampur | |
| Stok | Emergent BioSolutions Inc. | Bercampur | Menaik |
AISkor Stockmoo
| Konsensus Penganalisis | -0.5 |
| Aktiviti Orang Dalam | -1.5 |
| Volatiliti Harga | -2.0 |
| Purata Bergerak Teknikal | 2.5 |
| Osilator Teknikal | 2.0 |
| Purata | 0.10 |
|
Emergent BioSolutions Inc offers public health products to the government and healthcare providers. The company operates across three different segments, namely Commercial, Products, and Services. The Commercial Product Segment consisting of Nasal Spray; the MCM Products Segment consisting of Anthrax-MCM products, Smallpox-MCM products and Other Products and the Services Segment consisting of Bioservices portfolio. The key revenue is generated through the commercial segment which consists of NARCAN and other commercial products. |
|
| Sektor | Healthcare |
| Industri | Drug Manufacturers - Specialty & Generic |
| Gaya Pelaburan | Small Value |
| % Dimiliki oleh Orang Dalam | 2.28% |
| % Dimiliki oleh Institusi | 64.57% |
Pemilikan
| Nama | Tarikh | Syer Dipegang |
|---|---|---|
| Palisade Capital Management, Lp | 31 Mar 2025 | 1,141,589 |
| Oak Hill Advisors Lp | 31 Mar 2025 | 1,113,338 |
| Julat 52 Minggu | ||
| Median | 15.00 (135.85%) | |
| Jumlah | 1 Beli | |
| Syarikat | Tarikh | Harga Sasaran | Panggilan | Harga @ Panggilan |
|---|---|---|---|---|
| HC Wainwright & Co. | 01 Apr 2025 | 15.00 (135.85%) | Beli | 4.74 |
| 21 Mar 2025 | 15.00 (135.85%) | Beli | 5.72 |
| Nama | Purata Belian ($) | Purata Jualan ($) | Jumlah Net | Jumlah Nilai Bersih ($) |
|---|---|---|---|---|
| KATKIN KEITH | - | 6.40 | -7,844 | -50,202 |
| Jumlah Keseluruhan Kuantiti Bersih | -7,844 | |||
| Jumlah Keseluruhan Nilai Bersih ($) | -50,202 | |||
| Purata Pembelian Keseluruhan ($) | - | |||
| Purata Jualan Keseluruhan ($) | 6.40 | |||
| Nama | Pemegang | Tarikh | Jenis | Kuantiti | Harga | Nilai ($) |
|---|---|---|---|---|---|---|
| KATKIN KEITH | Pengarah | 23 May 2025 | Jual automatik (-) | 7,844 | 6.40 | 50,202 |
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2025 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |